BE840193A - Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain - Google Patents

Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain

Info

Publication number
BE840193A
BE840193A BE165690A BE165690A BE840193A BE 840193 A BE840193 A BE 840193A BE 165690 A BE165690 A BE 165690A BE 165690 A BE165690 A BE 165690A BE 840193 A BE840193 A BE 840193A
Authority
BE
Belgium
Prior art keywords
polypeptides
humans
allergic reactions
based agents
blocking allergic
Prior art date
Application number
BE165690A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE840193A publication Critical patent/BE840193A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1002—Tetrapeptides with the first amino acid being neutral
    • C07K5/1005—Tetrapeptides with the first amino acid being neutral and aliphatic
    • C07K5/1013—Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing O or S as heteroatoms, e.g. Cys, Ser
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
BE165690A 1975-04-04 1976-03-30 Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain BE840193A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US56542575A 1975-04-04 1975-04-04

Publications (1)

Publication Number Publication Date
BE840193A true BE840193A (fr) 1976-09-30

Family

ID=24258538

Family Applications (1)

Application Number Title Priority Date Filing Date
BE165690A BE840193A (fr) 1975-04-04 1976-03-30 Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain

Country Status (4)

Country Link
US (1) US4161522A (fr)
JP (1) JPS602318B2 (fr)
BE (1) BE840193A (fr)
DE (1) DE2602443A1 (fr)

Families Citing this family (48)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4356119A (en) * 1978-09-28 1982-10-26 Nordisk Insulinlaboratorium Therapeutically active polypeptides or acid addition salts and a process for producing such compounds
DE2846412A1 (de) * 1978-10-25 1980-05-08 Behringwerke Ag Mittel zur behandlung allergischer reaktionen
US4396606A (en) * 1979-11-05 1983-08-02 Addiction Research Foundation Novel polypeptide analgesics
US4290944A (en) * 1980-07-31 1981-09-22 Northwestern University Antigenic peptide compound
US4529543A (en) * 1981-02-24 1985-07-16 Newport Pharmaceuticals International Hepatosin
JPS58501469A (ja) * 1981-09-21 1983-09-01 ノ−スウエスタン・ユニバ−シテイ 抗原性ペプチド化合物
US4472305A (en) * 1983-05-17 1984-09-18 Sterling Drug Inc. Hexapeptide amides
US4753927A (en) * 1983-08-12 1988-06-28 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US4683292A (en) * 1983-08-12 1987-07-28 Immunetech, Inc. Immunotherapeutic polypeptide agents which bind to lymphocyte immunoglobulin FC receptors
US4579840A (en) * 1983-08-12 1986-04-01 Immunetech Pharmaceuticals Method of blocking immune complex binding to immunoglobulin Fc receptors
US5110795A (en) * 1984-08-09 1992-05-05 Immunetech Pharmaceuticals Methods and compositions for the treatment of inflammatory bowel diseases and conditions
US4816449A (en) * 1984-08-09 1989-03-28 Immunetech Pharmaceuticals Immunotherapeutic anti-inflammatory peptide agents
US4686282A (en) * 1983-08-12 1987-08-11 Immunetech, Inc. Immunotherapeutic polypeptide agents which block immune complex binding to immunoglobulin Fc receptors
US5468730A (en) * 1984-08-09 1995-11-21 Dura Pharmaceuticals, Inc. Methods for the treatment of non-IgE-mediated diseases
ZA846192B (en) * 1984-08-09 1986-03-26 Merck Patent Gmbh Immunotherapeutic polypeptide agents
FR2598422B1 (fr) * 1986-05-09 1989-12-08 Centre Nat Rech Scient Pseudo-peptide comportant au moins la sequence de l'acide g-glutamyl-aspartique ou l'un de ses derives, son utilisation dans la preparation d'une composition pharmaceutique et composition pharmaceutique en resultant
GB8616166D0 (en) * 1986-07-02 1986-08-06 Research Corp Ltd Polypeptide competitor
US5180805A (en) * 1986-07-02 1993-01-19 Research Corporation Limited Polypeptide competitor for immunoglobulin E
JPS63225397A (ja) * 1986-10-03 1988-09-20 Dainippon Pharmaceut Co Ltd 抗アレルギー作用を有する新規ペプチド
US5449760A (en) * 1987-12-31 1995-09-12 Tanox Biosystems, Inc. Monoclonal antibodies that bind to soluble IGE but do not bind IGE on IGE expressing B lymphocytes or basophils
US5231026A (en) * 1987-12-31 1993-07-27 Tanox Biosystems, Inc. DNA encoding murine-human chimeric antibodies specific for antigenic epitopes of IgE present on the extracellular segment of the membrane domain of membrane-bound IgE
US5422258A (en) * 1987-12-31 1995-06-06 Tanox Biosystems, Inc. Methods for producing high affinity anti-human IgE-monoclonal antibodies which binds to IgE on IgEabearing B cells but not basophils
US5091313A (en) * 1988-08-05 1992-02-25 Tanox Biosystems, Inc. Antigenic epitopes of IgE present on B cell but not basophil surface
US5252467A (en) * 1987-12-31 1993-10-12 Tanox Biosystems, Inc. Method of making antibodies to antigenic epitopes of IGE present on B cells but not basophil cell surface or secreted, soluble IGE
AU3184389A (en) * 1988-02-16 1989-09-06 Immunetech Pharmaceuticals Methods for treating immunoinflammatory and other disease conditions
JPH0742313B2 (ja) * 1988-03-28 1995-05-10 日立化成工業株式会社 新規ペプチド、その塩及びペプチド性抗アレルギー剤
US5292867A (en) * 1988-11-16 1994-03-08 Tanox Biosystems, Inc. Chimeric monoclonal antibodies which bind to the extracellular segment of the membrane-bound domain of a human membrane-bound immunoglobulin
US5212287A (en) * 1988-12-21 1993-05-18 Immunetech Pharmaceuticals, Inc. Pentapeptide synthesis
GB8905606D0 (en) * 1989-03-11 1989-04-26 Scras Peptides
DK122489D0 (da) * 1989-03-14 1989-03-14 Carlsberg Biotechnology Ltd Fremgangsmaade til fremstilling af pentapeptider samt mellemprodukter til brug ved fremstillingen
US5252464A (en) * 1989-03-14 1993-10-12 Carlsberg Biotechnology Ltd. A/S Process for producing pentapeptides and intermediates for use in the synthesis
US5955076A (en) * 1989-06-15 1999-09-21 Peptide Therapeutics Limited Immunoactive peptides and antibodies and their use in anti-allergy treatment
GB8913737D0 (en) * 1989-06-15 1989-08-02 Univ Birmingham A novel anti-allergy treatment
US5118669A (en) * 1989-09-20 1992-06-02 Hitachi Chemical Co., Ltd. Peptides and intermediates therefor useful as antiallergic agents, vasodilators and immunoregulators
US5223487A (en) * 1989-09-30 1993-06-29 Hitachi Chemical Co., Ltd. Peptides as antiallergic agents
US5965709A (en) * 1991-08-14 1999-10-12 Genentech, Inc. IgE antagonists
CA2128711C (fr) * 1992-01-30 2005-01-11 Terence K. Brunck Inhibiteurs de la trypsine
US5534498A (en) * 1992-01-30 1996-07-09 Corvas International, Inc. Trypsin inhibitors
US5371072A (en) * 1992-10-16 1994-12-06 Corvas International, Inc. Asp-Pro-Arg α-keto-amide enzyme inhibitors
ATE276272T1 (de) * 1993-06-18 2004-10-15 Curative Tech Inc Entzündungshemmende peptide
US5561146A (en) * 1994-06-10 1996-10-01 Bristol-Myers Squibb Company Modified guanidino and amidino thrombin inhibitors
US7404967B2 (en) * 1994-12-21 2008-07-29 Cosmederm, Inc. Topical product formulations containing strontium for reducing skin irritation
DK0885244T4 (da) 1996-03-01 2008-06-16 Novartis Ag Peptidimmunogener til vaccination imod og til behandling af allergi
WO1999043301A1 (fr) * 1998-02-24 1999-09-02 The Board Of Trustees Of The University Of Illinois Emulsions lipides pour le traitement de l'intoxication generale
WO2013166438A1 (fr) 2012-05-04 2013-11-07 The Board Of Regents Of The University Of Oklahoma Substrats et inhibiteurs de prolyle oligopeptidase et de protéine d'activation des fibroblastes et procédés d'utilisation
WO2015173802A1 (fr) * 2014-05-11 2015-11-19 Tel Hashomer Medical Research Infrastructure And Services Ltd. Conjugués thérapeutiques à base de par-1 et utilisations correspondantes
US11141398B2 (en) 2017-01-08 2021-10-12 The United States Government As Represented By The Department Of Veterans Affairs Methods for decreasing injuries associated with intraoperative hypotension
EP3787661B1 (fr) 2018-05-02 2023-10-18 Tel Hashomer Medical Research Infrastructure And Services Ltd. Combinaison de témozolomide et d'un conjugué de par-1 pour le traitement du glioblastome

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH427841A (de) 1959-08-24 1967-01-15 Ciba Geigy Verfahren zur Herstellung von a-(w-Aminoalkyl)-a-aminoessigsäuregruppenhaltigen Peptiden
CH436327A (de) 1962-12-10 1967-05-31 Sandoz Ag Verfahren zur Herstellung eines neuen Polypeptids
US3466368A (en) * 1967-06-02 1969-09-09 Us Health Education & Welfare Cleavage of human gamma globulin by means of cyanogen bromide
GB1212533A (en) 1967-09-04 1970-11-18 Nat Res Dev Improvements relating to peptide synthesis
GB1259870A (en) 1968-04-16 1972-01-12 Sandoz Ltd Polypeptides
IL31992A (en) 1968-05-08 1973-07-30 American Cyanamid Co Synthetic thyrocalcitonins and a method for their preparation
DE1941511C2 (de) 1968-08-23 1982-11-18 CIBA-GEIGY AG, 4002 Basel Calcitonin-Analoga und ihre α-Desamino- und N↑α↑-Acylaminoderivate, diese Peptide enthaltende pharmazeutische Präparate, und synthetische Verfahren zu ihrer Herstellung sowie zur Herstellung von Calcitonin M
DE1950711A1 (de) 1968-10-15 1970-04-30 Ciba Geigy Neue Peptide und Verfahren zu ihrer Herstellung
NL165454C (nl) 1969-05-05 1981-04-15 Lilly Co Eli Werkwijze ter bereiding van peptiden.
DE1924802A1 (de) 1969-05-14 1970-11-19 Hoechst Ag Verfahren zur Herstellung argininhaltiger Peptiden
US3664994A (en) * 1969-06-30 1972-05-23 Upjohn Co Process for separating horse gamma globulin fractions by chromatography
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m
US3778426A (en) * 1970-12-16 1973-12-11 Research Corp Therapeutically useful polypeptides
US3763135A (en) * 1971-11-08 1973-10-02 Baxter Laboratories Inc Gamma globulin production from cohn fraction iii using polyethylene glycol
BE791604A (fr) 1971-11-19 1973-05-17 Lilly Co Eli Polypeptides et procedes de preparation de ceux-ci

Also Published As

Publication number Publication date
JPS51118702A (en) 1976-10-18
JPS602318B2 (ja) 1985-01-21
DE2602443C2 (fr) 1987-10-01
DE2602443A1 (de) 1976-10-21
US4161522A (en) 1979-07-17

Similar Documents

Publication Publication Date Title
BE840193A (fr) Agents a base de polypeptides pour le blocage des reactions allergiques chez l'etre humain
BR7604005A (pt) Conjunto de valvula desviadora e valvula misturadora aperfeicoado
BE838938A (fr) Comprimes efferverscents d'edulcorants
FR2299968A1 (fr) Dispositif d'
RO69967A (fr) Composition catalytique utilisee a l'ontention des acides nonsatures
FR2317533A1 (fr) Servomoteur d'assistance
FR2334862A1 (fr) Servomoteur d'assistance
FR2335379A1 (fr) Servomoteur d'assistance
BE831056A (fr) Mecanisme de blocage d'aubes
FR2307643A1 (fr) Dispositif d'ebarbage de pieces faconnees
FR2305670A1 (fr) Robinet d'arret
FR2304410A1 (fr) Tourniquet d'arrosage
FR2321061A1 (fr) Servomoteur d'assistance
BE835561A (fr) Crochet d'accouplement
BE851816A (fr) Perles d'auxiliaires de detergence
FR2298966A1 (fr) Dispositif d'eplucha
FR2298855A1 (fr) Dispositif d'in
FR2302532A1 (fr) Dispositif d'ecartometrie
ATA187476A (de) Mischbatterie-umstellvorrichtung
FR2330926A1 (fr) Elements d'etancheite
FR2318135A1 (fr) Oxychloruration de l'ethylene
FR2302232A1 (fr) Stoppeur d'aussiere
FR2319825A1 (fr) Dispositif d'etanchement
AR210896A1 (es) Complejos de cromo asimetricos 1:2
FR2302533A1 (fr) Dispositif d'ecartometrie

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

Effective date: 19960330